Evidence map›Paper›PMID 28539401›Full record

ArticleMolecular biology of the cell2017

Transmembrane helix hydrophobicity is an energetic barrier during the retrotranslocation of integral membrane ERAD substrates.

Christopher J Guerriero, Karl-Richard Reutter, Andrew A Augustine, G Michael Preston, Kurt F Weiberth, Timothy D Mackie, Hillary C Cleveland-Rubeor, Neville P Bethel, Keith M Callenberg, Kunio Nakatsukasa and 2 more

Open access · greenAbstract read
In one paragraph

Article in Molecular biology of the cell, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. The Dsc complex and its role in Golgi quality control.Biochemical Society transactions · 2024
    Review
  4. Article
  5. The AAA+ protein Msp1 recognizes substrates by a hydrophobic mismatch.bioRxiv : the preprint server for biology · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Protein quality control in the secretory pathway.The Journal of cell biology · 2019
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Christopher J GuerrieroDepartment of Biological Sciences, University of Pittsburgh, Pittsburgh, PA 15260.
Karl-Richard ReutterDepartment of Biological Sciences, University of Pittsburgh, Pittsburgh, PA 15260.
Andrew A AugustineDepartment of Biological Sciences, University of Pittsburgh, Pittsburgh, PA 15260.
G Michael PrestonDepartment of Biological Sciences, University of Pittsburgh, Pittsburgh, PA 15260.
Kurt F WeiberthDepartment of Biological Sciences, University of Pittsburgh, Pittsburgh, PA 15260.
Timothy D MackieDepartment of Biological Sciences, University of Pittsburgh, Pittsburgh, PA 15260.
Hillary C Cleveland-RubeorDepartment of Biological Sciences, University of Pittsburgh, Pittsburgh, PA 15260.
Neville P BethelCardiovascular Research Institute, Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA 94158.
Keith M CallenbergDepartment of Biological Sciences, University of Pittsburgh, Pittsburgh, PA 15260.
Kunio NakatsukasaDepartment of Biological Sciences, University of Pittsburgh, Pittsburgh, PA 15260.
Michael GrabeCardiovascular Research Institute, Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA 94158.
Jeffrey L BrodskyDepartment of Biological Sciences, University of Pittsburgh, Pittsburgh, PA 15260 jbrodsky@pitt.edu.
University of Pittsburgh · USUniversity of California, San Francisco · US

Funding

Single Nephron and MetabolomicsP30DK079307 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KLEYMAN, THOMAS R · 2008 to 2022
$13.4M
Translational StudiesP30DK072506 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SWIATECKA-URBAN, AGNIESZKA · 2005 to 2017
$12.5M
ER Associated Degradation of Membrane Proteins in YeastR01GM075061 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BRODSKY, JEFFREY L. · 2006 to 2019
$3.2M
Integrative Program in Complex Biological System (ipCBS)T32EB009383 · NIBIB · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MARSHALL, WALLACE, WEINER, ORION D · 2009 to 2022
$3.2M
Renal and Epithelial Biology Training ProgramT32DK061296 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KLEYMAN, THOMAS R · 2002 to 2022
$3.1M
A Multiscale Model of Protein Mediated Changes in membrane MorphologyR01GM117593 · NIGMS · COLORADO STATE UNIVERSITY · PI ZHOU, YONGCHENG · 2015 to 2019
$1.8M
Experimental and Computational Modeling of ERAD Substrate RetrotranslocationK01DK101584 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GUERRIERO, CHRISTOPHER JAMES · 2014 to 2018
$529k
NIBIB NIH HHS T32 EB009383NIDDK NIH HHS K01 DK101584NIDDK NIH HHS P30 DK072506NIDDK NIH HHS P30 DK079307NIDDK NIH HHS T32 DK061296NIGMS NIH HHS R01 GM075061NIGMS NIH HHS R01 GM117593
6 · The paper itself

Abstract

Integral membrane proteins fold inefficiently and are susceptible to turnover via the endoplasmic reticulum-associated degradation (ERAD) pathway. During ERAD, misfolded proteins are recognized by molecular chaperones, polyubiquitinated, and retrotranslocated to the cytoplasm for proteasomal degradation. Although many aspects of this pathway are defined, how transmembrane helices (TMHs) are removed from the membrane and into the cytoplasm before degradation is poorly understood. In this study, we asked whether the hydrophobic character of a TMH acts as an energetic barrier to retrotranslocation. To this end, we designed a dual-pass model ERAD substrate, Chimera A*, which contains the cytoplasmic misfolded domain from a characterized ERAD substrate, Sterile 6* (Ste6p*). We found that the degradation requirements for Chimera A* and Ste6p* are similar, but Chimera A* was retrotranslocated more efficiently than Ste6p* in an in vitro assay in which retrotranslocation can be quantified. We then constructed a series of Chimera A* variants containing synthetic TMHs with a range of Δ

Indexed as

Adenosine TriphosphatasesCell Cycle ProteinsEndoplasmic ReticulumEndoplasmic Reticulum-Associated DegradationHydrophobic and Hydrophilic InteractionsMembrane ProteinsMembranesMutationProteasome Endopeptidase ComplexProtein FoldingProtein Translocation SystemsProtein TransportSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsUbiquitinUbiquitinationAdenosine TriphosphatasesCell Cycle ProteinsMembrane ProteinsProteasome Endopeptidase ComplexProtein Translocation SystemsSaccharomyces cerevisiae ProteinsUbiquitinUbiquitin-Protein Ligases

Identifiers

PMID28539401
PMCPMC5509421
OpenAlexW2620153543

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.